Acalabrutinib
CAS 1420477-60-6
In Stock
Acalabrutinib
Cat. No. STUB-API-ACALABRUTINIBCAS 1420477-60-6In Stock
Technical Data
Cat. No.STUB-API-ACALABRUTINIB
CAS1420477-60-6
Mol. FormulaC26H23N7O2
Mol. Weight465.517 g/mol
IUPAC4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide
SMILESCC#CC(=O)N1CCC[C@H]1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5
InChIInChI=1S/C26H23N7O2/c1-2-6-21(34)32-15-5-7-19(32)25-31-22(23-24(27)29-14-16-33(23)25)17-9-11-18(12-10-17)26(35)30-20-8-3-4-13-28-20/h3-4,8-14,16,19H,5,7,15H2,1H3,(H2,27,29)(H,28,30,35)/t19-/m0/s1
InChI KeyWDENQIQQYWYTPO-IBGZPJMESA-N
Purity—
Description
Overview
Acalabrutinib is used to treat mantle cell lymphoma (MCL) in adults who have received at least one previous treatment for their cancer
Anant Labs manufacture and furnish high quality Acalabrutinib impurities for global markets. Our Acalabrutinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
Acalabrutinib1420477-60-6ACP-196acalabrutinibumI42748ELQW4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamideBenzamide, 4-[8-amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinyl-CHEBI:167707DTXSID4010262094-[8-Amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinylbenzamide
